Paper2931964
The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular diseases.
De Cree J and 4 others. Agents Actions, 1985. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular diseases. Papers, record 2931964. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2931964
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular diseases.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiovascular Diseases | Major topic |
| Piperidines | Major topic |
| Platelet Aggregation | Major topic |
| Serotonin | Major topic |
| Aged | |
| Arterial Occlusive Diseases | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Ketanserin | |
| Male | |
| Middle Aged | |
| Myocardial Infarction | |
| Placebos | |
| beta-Thromboglobulin |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5447960 | A biphasic response of platelets to serotonin. | Scand J Haematol | 1970 | https://conductscience.org/library/papers/5447960 | PubMed |
| 2 | 6113280 | Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. | J Pharmacol Exp Ther | 1981 | https://conductscience.org/library/papers/6113280 | PubMed |
| 3 | 6158764 | beta-Thromboglobulin--a specific marker of in-vivo platelet release reaction. | Thromb Haemost | 1980 | https://conductscience.org/library/papers/6158764 | PubMed |
| 4 | 6183969 | Plasma beta-thromboglobulin as a measure of platelet activity. Effect of risk factors and findings in ischemic heart disease and after acute myocardial infarction. | Am J Cardiol | 1982 | https://conductscience.org/library/papers/6183969 | PubMed |
| 5 | 74664 | Elevated beta-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy. | Lancet | 1978 | https://conductscience.org/library/papers/74664 | PubMed |
| 6 | 7350460 | Platelet activation during exercise-induced myocardial ischemia. | N Engl J Med | 1980 | https://conductscience.org/library/papers/7350460 | PubMed |
| 7 | 7148644 | In vivo platelet aggregation and plasma catecholamines in acute myocardial infarction. | Am Heart J | 1982 | https://conductscience.org/library/papers/7148644 | PubMed |
| 8 | 6193378 | Prognostic value of beta-thromboglobulin in patients with transient cerebral ischaemia. | Lancet | 1983 | https://conductscience.org/library/papers/6193378 | PubMed |
| 9 | 6710435 | The involvement of 5-HT2-receptor sites in the activation of cat platelets. | Thromb Res | 1984 | https://conductscience.org/library/papers/6710435 | PubMed |
| 10 | 621432 | Elevation of platelet factor four in acute myocardial infarction: measurement by radioimmunoassay. | J Lab Clin Med | 1978 | https://conductscience.org/library/papers/621432 | PubMed |
| 11 | 6261070 | Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. | Life Sci | 1981 | https://conductscience.org/library/papers/6261070 | PubMed |
| 12 | 4744691 | Platelet abnormalities in ischemic heart disease. | Am J Cardiol | 1973 | https://conductscience.org/library/papers/4744691 | PubMed |
| 13 | 6612677 | Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets. | Thromb Res | 1983 | https://conductscience.org/library/papers/6612677 | PubMed |
| 14 | 7011110 | The antihypertensive effects of a pure and selective serotonin-receptor blocking agent (R 41 468) in elderly patients. | Angiology | 1981 | https://conductscience.org/library/papers/7011110 | PubMed |
| 15 | 6800533 | Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6800533 | PubMed |
| 16 | 4696737 | Adenosine diphosphate induced platelet aggregation in myocardial infarction and ischemic heart disease. | Atherosclerosis | 1973 | https://conductscience.org/library/papers/4696737 | PubMed |
| 17 | 6817452 | Platelet-mediated vascular contractions: inhibition of the serotonergic component by ketanserin. | Thromb Res | 1982 | https://conductscience.org/library/papers/6817452 | PubMed |
| 18 | 7455982 | Platelet aggregates in ischemic heart disease. | Thromb Haemost | 1980 | https://conductscience.org/library/papers/7455982 | PubMed |
| 19 | 4512589 | Influence of lysolecithin on platelet aggregation initiated by 5-hydroxytryptamine. | Nat New Biol | 1973 | https://conductscience.org/library/papers/4512589 | PubMed |
| 20 | 6854135 | Plasma platelet products and exercise-induced myocardial ischemia. | J Lab Clin Med | 1983 | https://conductscience.org/library/papers/6854135 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8453957 | Serotonin-induced platelet aggregation predicts the antihypertensive response to serotonin receptor antagonists. | Eur J Clin Pharmacol | 1993 | https://conductscience.org/library/papers/8453957 | PubMed |
| 3240733 | Hyperreactivity of platelets to serotonin (5-hydroxytryptamine) in patients with cardiovascular diseases. Influence of ketanserin, a serotonin S2-receptor antagonist. | Drugs | 1988 | https://conductscience.org/library/papers/3240733 | PubMed |
| 2939698 | Effects of ketanserin, a selective 5-HT2 serotonergic antagonist, on the secondary recruitment of human platelets in vitro. | Agents Actions | 1986 | https://conductscience.org/library/papers/2939698 | PubMed |
| 2467792 | Serotonin metabolism and age-related effects of antihypertensive therapy with ketanserin. | Drugs | 1988 | https://conductscience.org/library/papers/2467792 | PubMed |
| 2285642 | Comparison of ketanserin and enalapril in the treatment of mild-to-moderate essential hypertension. | Cardiovasc Drugs Ther | 1990 | https://conductscience.org/library/papers/2285642 | PubMed |
| 2079001 | Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease. | Drugs | 1990 | https://conductscience.org/library/papers/2079001 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HTR2A | 3356 | PubTator's text mining | https://conductscience.org/library/genes/3356 | NCBI Gene |
| PPBP | 5473 | PubTator's text mining | https://conductscience.org/library/genes/5473 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2931964
GET https://conductscience.org/api/papers/v1/2931964/references?page=2